Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,259,453
+$247,533 QoQ
Shares Held
3,478
+20.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,537
of 3,139 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. AMGN ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,340 | $16,000,397 | |
| 2 | JNJ |
Johnson & Johnson
|
12,027 | $3,054,497 | |
| 3 | ABBV |
AbbVie Inc.
|
10,728 | $2,699,593 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,671 | $2,270,723 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,478 | $1,259,453 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
20,481 | $1,180,115 | |
| 7 | PFE |
Pfizer Inc
|
45,408 | $1,093,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,111 | $898,403 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,259,453 | 3,478 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,011,920 | 2,876 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,132,165 | 3,459 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,078,004 | 3,820 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,004,318 | 3,597 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,549,876 | 14,604 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,964,334 | 15,210 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,839,916 | 15,021 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,197,293 | 16,634 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,489,128 | 15,789 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,984,468 | 13,834 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,978,935 | 11,084 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $203,814 | 918 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $231,354 | 957 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $257,124 | 979 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $224,273 | 995 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $249,139 | 1,024 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $253,185 | 1,047 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $233,277 | 1,097 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $274,950 | 1,128 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $281,404 | 1,131 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $266,477 | 1,159 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $303,212 | 1,193 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $293,645 | 1,245 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $321,327 | 1,585 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||